Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
COM701 is an antibody directed against PVRIG, which interferes with binding to its ligand PVRL2, potentially resulting in increased anti-tumor immune response (J Clin Oncol 35, 2017 (suppl; abstr 3074), PMID: 32345592).
|CAS Registry Number||2253186-93-3|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|BMS-986207 + COM701 + Nivolumab||BMS-986207 COM701 Nivolumab||0||1|
|COM701 + Nivolumab||COM701 Nivolumab||0||1|